Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight​Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight 

Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she said. The 31-year-old compliance consultant from Hendersonville, Tennessee, said she couldn’t stop vomiting. “Sunday morning, it all hits,” McClain recalled, as she described what happened Read More

First comprehensive look at breast cancer in Native American women reveals key genetic differences​First comprehensive look at breast cancer in Native American women reveals key genetic differences 

Researchers from the University of Notre Dame have published the first known detailed study of breast cancer tissue from Native American women. The study, published in npj Precision Oncology, reveals important molecular differences that may impact the efficacy of therapies for female, Native American breast cancer patients.

Q&A: Researcher discusses early-onset breast cancer in East Africa​Q&A: Researcher discusses early-onset breast cancer in East Africa 

Most breast cancer patients in Uganda and Ethiopia are diagnosed too late, and many lack access to life-saving treatment. Tove Ekdahl Hjelm defends her thesis “Early-onset breast cancer in East Africa: genetics, tumor characteristics and clinical management” on June 5, where she highlights deficiencies in access to adequate care, but also that more lives can be saved.

Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy​Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy 

Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy Millions of women with breast cancer could be spared chemotherapy with a groundbreaking genomic test, according to the results of a trial that could transform healthcare guidelines worldwide.Treatment for breast cancer, the world’s most prevalent form of the disease, involves surgery to remove tumours. Chemotherapy is then usually recommended when doctors believe there is a risk the disease will return. Continue reading…